Save your place

Sign in to WhoBought

Please try again later.

Relay Therapeutics, Inc. (RLAY) institutional ownership

Latest close $19.30 Jul 21, 2026
Market cap$576M 52-week range SectorHealthcare
Funds holding · Q1 2026
218
reported RLAY position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
135 buyers · 83 sellers

Relay Therapeutics, Inc. (RLAY) price and institutional activity

Dates

Q1 2026

$0 bought by 135 investors
Perceptive Advisors LLCFMR LLC +133 more
$0 sold by 83 investors
Point72 Asset Management, L.P.Two Sigma Advisers, LP +81 more
Bought Sold Totals per quarter; hover a bar for the names.

Relay Therapeutics, Inc. (RLAY) institutional activity · 218

Investor Type Est. change Change Δ Own Date
Point72 Asset Management, L.P. · Exited
Change −13.9M Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −13.9M −100.0% Q1 2026
Perceptive Advisors LLC · Added
Change +7.8M Date Q1 2026
Perceptive Advisors LLC Added· Q1 2026 +7.8M Q1 2026
FMR LLC · Added
Change +3.5M Δ Own +2178.0% Date Q1 2026
FMR LLC Added· Q1 2026 +3.5M +2178.0% Q1 2026
Adage Capital Partners Gp, L.L.C. · Added
Change +2.1M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Added· Q1 2026 +2.1M Q1 2026
Ecor1 Capital, LLC · New
Change +1.9M Date Q1 2026
Ecor1 Capital, LLC New· Q1 2026 +1.9M Q1 2026
Casdin Capital, LLC · Added
Change +1.4M Date Q1 2026
Casdin Capital, LLC Added· Q1 2026 +1.4M Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.3M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.3M −100.0% Q1 2026
Exoduspoint Capital Management, LP · Exited
Change −1.1M Δ Own −100.0% Date Q1 2026
Exoduspoint Capital Management, LP Exited· Q1 2026 −1.1M −100.0% Q1 2026
Tcg Crossover Management, LLC · Added
Change +1.1M Date Q1 2026
Tcg Crossover Management, LLC Added· Q1 2026 +1.1M Q1 2026
Marshall Wace, LLP · New
Change +942K Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +942K Q1 2026
Balyasny Asset Management L.P. · Added
Change +939K Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +939K Q1 2026
Bank of America Corp · Added
Change +897K Date Q1 2026
Bank of America Corp Added· Q1 2026 +897K Q1 2026
Norges · Exited
Change −837K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −837K −100.0% Q1 2026
Nextech Invest, Ltd. · Added
Change +825K Date Q1 2026
Nextech Invest, Ltd. Added· Q1 2026 +825K Q1 2026
Panagora Asset Management Inc · New
Change +818K Date Q1 2026
Panagora Asset Management Inc New· Q1 2026 +818K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 218

Famous investor activity in Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. (RLAY) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Patel Sanjiv · Director Sell −$944K
Price $19.58 Qty −48K Owned 616K ΔOwn −7.3% Trade date Jul 7, 2026 Filed date Jul 8, 2026
Patel Sanjiv Director Sell $19.58 −48K −$944K 616K −7.3% Jul 7, 2026 Jul 8, 2026
Bergstrom Donald A. · Officer Sell −$162K
Price $18.71 Qty −9K Owned 410K ΔOwn −2.1% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Bergstrom Donald A. Officer Sell $18.71 −9K −$162K 410K −2.1% Jul 6, 2026 Jul 8, 2026
Catinazzo Thomas · Officer Sell −$331K
Price $18.69 Qty −18K Owned 160K ΔOwn −10.0% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Catinazzo Thomas Officer Sell $18.69 −18K −$331K 160K −10.0% Jul 6, 2026 Jul 8, 2026
Patel Sanjiv · Director Grant (A) $21K
Price $6.95 Qty 3K Owned 664K ΔOwn +0.5% Trade date Jun 30, 2026 Filed date Jul 8, 2026
Patel Sanjiv Director Grant (A) $6.95 3K $21K 664K +0.5% Jun 30, 2026 Jul 8, 2026
Rahmer Peter · Officer Sell −$954K
Price $19.09 Qty −50K Owned 226K ΔOwn −18.1% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Rahmer Peter Officer Sell $19.09 −50K −$954K 226K −18.1% Jun 30, 2026 Jul 2, 2026
Rahmer Peter · Officer Grant (A) $21K
Price $6.95 Qty 3K Owned 229K ΔOwn +1.4% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Rahmer Peter Officer Grant (A) $6.95 3K $21K 229K +1.4% Jun 30, 2026 Jul 2, 2026
Catinazzo Thomas · Officer 4 operations −$3.2M
Price $16.97–$17.01 Qty −187K Owned 177K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Catinazzo Thomas Officer 4 operations $16.97–$17.01 −187K −$3.2M 177K Jun 22, 2026 Jun 24, 2026
Catinazzo Thomas · Officer 6 operations 0
Price $4.45–$5.22 Owned 223K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Catinazzo Thomas Officer 6 operations $4.45–$5.22 0 223K Jun 22, 2026 Jun 24, 2026
Bergstrom Donald A. · Officer Sell −$1.6M
Price $16.94 Qty −93K Owned 419K ΔOwn −18.3% Trade date Jun 22, 2026 Filed date Jun 24, 2026
Bergstrom Donald A. Officer Sell $16.94 −93K −$1.6M 419K −18.3% Jun 22, 2026 Jun 24, 2026
Bergstrom Donald A. · Officer 2 operations 0
Price $4.12 Owned 0 Trade date Jun 22, 2026 Filed date Jun 24, 2026
Bergstrom Donald A. Officer 2 operations $4.12 0 0 Jun 22, 2026 Jun 24, 2026
Mazumdar Claire · Director Grant (A) 33K
Owned 33K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Mazumdar Claire Director Grant (A) 33K 33K Jun 9, 2026 Jun 10, 2026
Dable Habib J. · Director Grant (A) 33K
Owned 33K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Dable Habib J. Director Grant (A) 33K 33K Jun 9, 2026 Jun 10, 2026
Hill Linda A. · Director Grant (A) 33K
Owned 33K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Hill Linda A. Director Grant (A) 33K 33K Jun 9, 2026 Jun 10, 2026
Borisy Alexis · Director Grant (A) 33K
Owned 33K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Borisy Alexis Director Grant (A) 33K 33K Jun 9, 2026 Jun 10, 2026
Ingram Douglas S. · Director Grant (A) 33K
Owned 33K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Ingram Douglas S. Director Grant (A) 33K 33K Jun 9, 2026 Jun 10, 2026
15 of 53
15 of 53 Sign in to continue to older insider transactions.

Relay Therapeutics, Inc. (RLAY) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 10.7M
% of shares outstanding 8.6% Filing date Feb 13, 2024
Vanguard Group Inc 10.7M 8.6% Feb 13, 2024
BlackRock Inc. 9.6M
% of shares outstanding 7.8% Filing date Jan 26, 2024
BlackRock Inc. 9.6M 7.8% Jan 26, 2024
Casdin Capital, LLC 7.4M
% of shares outstanding 6.0% Filing date Feb 14, 2024
Casdin Capital, LLC 7.4M 6.0% Feb 14, 2024
Commodore Capital LP 10.0M
% of shares outstanding 5.8% Filing date May 15, 2025
Commodore Capital LP 10.0M 5.8% May 15, 2025
State Street Corp
% of shares outstanding 4.0% Filing date Jan 23, 2024
State Street Corp 4.0% Jan 23, 2024
T. Rowe Price Associates 5.3M
% of shares outstanding 3.3% Filing date Nov 14, 2024
T. Rowe Price Associates 5.3M 3.3% Nov 14, 2024
FMR LLC 3.0M
% of shares outstanding 2.4% Filing date Jul 10, 2023
FMR LLC 3.0M 2.4% Jul 10, 2023
Point72 Asset Management, L.P. 0
% of shares outstanding 0.0% Filing date May 15, 2026
Point72 Asset Management, L.P. 0 0.0% May 15, 2026
8 of 9

Relay Therapeutics, Inc. (RLAY) ownership FAQ

Who owns RLAY?

218 reporting institutions disclosed RLAY position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.